Harry Subramanian
Papers
1
Total Citations
11
H-Index
1
About
Harry Subramanian is a head and neck surgeon whose research focuses on refining treatment strategies for oropharyngeal squamous cell carcinoma, particularly through the lens of transoral robotic surgery (TORS). His most cited work, a 2016 case-control study, made a critical contribution by identifying preoperative predictors—such as positive surgical margins and lymph node extracapsular extension—that necessitate adjuvant chemoradiation after TORS. This research helps clinicians better stratify patients, potentially sparing some from the added toxicity of chemoradiation while ensuring others receive necessary aggressive therapy. Though his citation count is modest, with his top paper garnering 11 citations, the clinical relevance of his findings is significant for the growing field of de-escalation protocols in head and neck oncology. Subramanian’s work exemplifies the push toward personalized, minimally invasive surgical approaches, offering practical guidance for treatment planning. His contributions are particularly valuable for surgeons and oncologists seeking to balance oncologic control with quality of life, marking him as a thoughtful voice in the evolving landscape of oropharyngeal cancer management.
Research Focus
Key Achievements
Top Papers
- 1